Zambia's use of resources to fight HIV/AIDS model for other countries

Zambia has demonstrated how to use donor funding effectively for HIV prevention and treatment programs at the community and ministerial levels, and the country could serve as a model for other nations, Mark Dybul -- who serves as the U.S. global AIDS coordinator and administers the President's Emergency Plan for AIDS Relief -- said on Friday during a visit to the country, Zambia's Daily Mail reports.

"Zambia is an extraordinary example of what partnership can do.

The successes that this nation has scored in care and treatment of patients is remarkable," Dybul said of the partnerships between the Ministry of Health and communities aimed at preventing the spread and alleviating the impact of HIV.

During his trip, Dybul also met with people living with HIV/AIDS at the Kanyama Clinic in the capital, Lusaka, which is providing antiretroviral drugs to 3,400 people and long-term care to 6,000 adults and children.

According to the Daily Mail, Dybul said PEPFAR has spent $570 million on HIV/AIDS programs in Zambia (Chileshe, Daily Mail, 10/21).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response